(Total Views: 568)
Posted On: 03/05/2021 6:28:53 PM
Post# of 145890
Could be, and hope so. Just wondering why NP says running a bigger trial then. I figured 62 subjects may not be big enough for FDA. With our safety profile though, why not?
I think we can guess why overall mortality just 22% in our trial .. most of them were severe not critical (just 15%), and so less of them died.
Would love to hear more about how the discussions are going.
I think we can guess why overall mortality just 22% in our trial .. most of them were severe not critical (just 15%), and so less of them died.
Would love to hear more about how the discussions are going.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)